Joseph Araujo
Founder bij MINDSET PHARMA INC.
Vermogen: 66 600 $ op 31-10-2023
Profiel
Joseph Araujo is the founder of CanCog Technologies, Inc. (founded in 2002), Karyopharm Therapeutics, Inc. (founded in 2008), and Mindset Pharma, Inc. (founded in 2019), where he held various executive titles.
He currently holds director positions at Vivocore, Inc. and Transpharmation Ltd.
He previously served as President & Chief Executive Officer at InterVivo Solutions, Inc. from 2010 to 2023.
Mr. Araujo received an undergraduate degree from the University of Toronto.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
MINDSET PHARMA INC.
0.09% | 31-08-2023 | 90 000 ( 0.09% ) | 66 600 $ | 31-10-2023 |
Actieve functies van Joseph Araujo
Bedrijven | Functie | Begin |
---|---|---|
MINDSET PHARMA INC. | Founder | 07-10-2019 |
CanCog Technologies, Inc.
CanCog Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services CanCog Technologies, Inc. operates as a contract research organization providing non-invasive research and development services in the companion animal market. The firm's services include food intake, cognitive assessment, activity and movement, imaging and special technologies. The company was founded by Norton William Milgram and David R. Stevens in 2002 and is headquartered in Toronto, Canada. | Chief Executive Officer | 01-03-2022 |
Vivocore, Inc.
Vivocore, Inc. Miscellaneous Commercial ServicesCommercial Services Vivocore, Inc. is a non-invasive research and Canadian development company. | Director/Board Member | - |
Transpharmation Ltd.
Transpharmation Ltd. BiotechnologyHealth Technology Part of Vivocore, Inc., Transpharmation Ltd. is a contract research organization. The private company is based in London, UK. The British company was founded in 2010 by Neil Upton, Mark Steven Duxon. Mark Steven Duxon has been the CEO since 2010. Transpharmation was acquired by Vivocore, Inc. on February 07, 2022. | Director/Board Member | 16-09-2021 |
Eerdere bekende functies van Joseph Araujo
Bedrijven | Functie | Einde |
---|---|---|
InterVivo Solutions, Inc.
InterVivo Solutions, Inc. Miscellaneous Commercial ServicesCommercial Services InterVivo Solutions, Inc. offers high-quality, translational drug discovery services to accelerate drug discovery programs to the clinic. The Canadian company provides a carefully selected array of neuroscience models and experiments to help propel new drugs forward through the development track. The private company's designed pharmacokinetics studies provide reliable data ensuring faster screening, selection, and development of lead candidates. The company has expertise in neurological disease models and laboratory testing capabilities to support emerging research. The company welcomes inquiries for novel approaches for model and bioanalytical development. Additionally, Transpharmation, a preclinical neuroscience CRO, relays a number of natural models of disease via the largest world-class canine colony in the industry. InterVivo Solutions can assist in discovering how they can help. | Chief Executive Officer | 01-03-2023 |
KARYOPHARM THERAPEUTICS INC. | Founder | 01-09-2010 |
Opleiding van Joseph Araujo
University of Toronto | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
KARYOPHARM THERAPEUTICS INC. | Health Technology |
Bedrijven in privébezit | 5 |
---|---|
CanCog Technologies, Inc.
CanCog Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services CanCog Technologies, Inc. operates as a contract research organization providing non-invasive research and development services in the companion animal market. The firm's services include food intake, cognitive assessment, activity and movement, imaging and special technologies. The company was founded by Norton William Milgram and David R. Stevens in 2002 and is headquartered in Toronto, Canada. | Commercial Services |
Mindset Pharma, Inc. | |
InterVivo Solutions, Inc.
InterVivo Solutions, Inc. Miscellaneous Commercial ServicesCommercial Services InterVivo Solutions, Inc. offers high-quality, translational drug discovery services to accelerate drug discovery programs to the clinic. The Canadian company provides a carefully selected array of neuroscience models and experiments to help propel new drugs forward through the development track. The private company's designed pharmacokinetics studies provide reliable data ensuring faster screening, selection, and development of lead candidates. The company has expertise in neurological disease models and laboratory testing capabilities to support emerging research. The company welcomes inquiries for novel approaches for model and bioanalytical development. Additionally, Transpharmation, a preclinical neuroscience CRO, relays a number of natural models of disease via the largest world-class canine colony in the industry. InterVivo Solutions can assist in discovering how they can help. | Commercial Services |
Vivocore, Inc.
Vivocore, Inc. Miscellaneous Commercial ServicesCommercial Services Vivocore, Inc. is a non-invasive research and Canadian development company. | Commercial Services |
Transpharmation Ltd.
Transpharmation Ltd. BiotechnologyHealth Technology Part of Vivocore, Inc., Transpharmation Ltd. is a contract research organization. The private company is based in London, UK. The British company was founded in 2010 by Neil Upton, Mark Steven Duxon. Mark Steven Duxon has been the CEO since 2010. Transpharmation was acquired by Vivocore, Inc. on February 07, 2022. | Health Technology |